How George Santos and Al Owens’s early Cytoxan studies led to standard-of-care therapy in BMT

Update: 2023-11-10

Description

George Santos, founder of Johns Hopkins University Bone Marrow Transplantation Program, pioneered many of the innovations used in bone marrow transplantation that are relevant today—but he didn’t get nearly as much credit as others working in the field.

Richard J. Jones, professor of oncology and medicine, director of the Bone Marrow Transplantation Program, and co-director, Hematologic Malignancies Program, at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, spoke with the Cancer History Project about George Santos's legacy.

“Much of what we’re currently doing in bone marrow transplant internationally was developed by George,” Jones said.

A transcript of this conversation is available here.

Comments

In Channel

How Susan Ellenberg went from school teacher to leading biostatistician

2024-10-2545:21

Latino oncology leaders discuss representation in clinical trials, translational research, and health care

2024-10-1153:20

Lung cancer couldn’t slow down physician and athlete Lawrence Phillips

2024-09-0655:06

Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor

2024-07-1201:01:17

2024 Karnofsky Award winner Lillian Siu talks about her career in phase I studies, ctDNA, and her mentor’s “evil red pencil”

2024-05-1035:24

Surviving lung cancer focused Morhaf Al Achkar’s career on addressing health disparities

2024-04-1943:02

How “Dr. Susan Love’s Breast Book” has remained the “bible” for women with breast cancer since 1990

2024-03-2930:34

Weeks before death from sarcoma, Norm Coleman reflected on his career in radiation oncology, addressing health disparities

2024-03-2201:05:43

NIH ORWH’s Vivian Pinn on being the second Black woman graduate of UVA med school

2024-03-0142:17

Roderic Pettigrew on a career as a “physicianeer” and the early days of the MRI: “You don’t make advances without technological innovation.”

2024-02-2301:03:24

Former HHS Secretary Louis Sullivan on sinking RJR’s “Uptown,” a menthol brand for Black smokers

2024-01-1901:11:43

Don Shopland: Writing the 1964 Surgeon General’s Report on Smoking and Health

2024-01-0501:12:11

How George Santos and Al Owens’s early Cytoxan studies led to standard-of-care therapy in BMT

2023-11-1038:10

Judith L. Pearson on how Mary Lasker made the National Cancer Act happen

2023-09-2244:15

Chris Lundy had one week to live; 52 years later, he is the longest living BMT recipient at the Hutch

2023-09-1501:18:14

John Laszlo: Finding the cure for childhood leukemia and writing a book about it

2023-08-1158:52

How CAR T cell therapy resulted in a complete remission in two subtypes of lymphoma

2023-06-0201:23:54

Hagop Kantarjian on changing the course of leukemias from mostly incurable to mostly curable

2023-05-2638:34

Fred Appelbaum on the genesis of bone marrow transplantation and Don Thomas’s Nobel-prize-winning discoveries

2023-05-1939:25

Patient stories: Sandra Hillburn on receiving a pathbreaking treatment for glioblastoma multiforme

2023-04-2828:45

00:00

How George Santos and Al Owens’s early Cytoxan studies led to standard-of-care therapy in BMT

#box-pro-ellipsis-176600811485618{-webkit-line-clamp:2;}How George Santos and Al Owens’s early Cytoxan studies led to standard-of-care therapy in BMT

How George Santos and Al Owens’s early Cytoxan studies led to standard-of-care therapy in BMT

Cancer History Project

How George Santos and Al Owens’s early Cytoxan studies led to standard-of-care therapy in BMT